Alcohol consumption is associated with lower self-reported disease activity and better health-related quality of life in female rheumatoid arthritis patients in Sweden: Data from BARFOT, a multicenter study on early RA

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Bergman, Stefan ^a,b   Symeonidou, Sofia ^b   Andersson, Maria L ^b   Söderlin, Maria K ^b  

^a LUND UNIVERSITY   (Sweden)

^b Spenshult Rheumatology Hospital   (Sweden)

Author keywords

Alcohol; EULAR response criteria; Health related quality of life; Rheumatoid arthritis

Indexed keywords

ALCOHOL;

AGED; ALCOHOL CONSUMPTION; ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SELF REPORT; SMOKING; SWEDEN;

ADULT; AGED; ALCOHOL DRINKING; ARTHRITIS, RHEUMATOID; EARLY DIAGNOSIS; FEMALE; HEALTH STATUS; HUMANS; MIDDLE AGED; POSTAL SERVICE; QUALITY OF LIFE; QUESTIONNAIRES; SELF REPORT; SEVERITY OF ILLNESS INDEX; SWEDEN;

EID: 84880375940     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-218     Document Type: Article

References (50)

1. Ethanol prevents development of destructive arthritis. Jonsson IM, Verdrengh M, Brisslert M, Lindblad S, Bokarewa M, Islander U, Carlsten H, Ohlsson C, Nandakumar KS, Holmdahl R, et al. Proc Natl Acad Sci U S A 2007 104 1 258 263 10.1073/pnas.0608620104 17185416 (Pubitemid 46068019)
2. Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Maxwell JR, Gowers IR, Moore DJ, Wilson AG, Rheumatology (Oxford, England) 2010 49 11 2140 2146 10.1093/rheumatology/keq202
3. The effect of alcohol on radiographic progression in rheumatoid arthritis. Nissen MJ, Gabay C, Scherer A, Finckh A, Arthritis and rheumatism 2010 62 5 1265 1272 10.1002/art.27388 20213811
4. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J, Frisch M, Arthritis research & therapy 2006 8 4 133 10.1186/ar2022 23908547
5. Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies. Kallberg H, Jacobsen S, Bengtsson C, Pedersen M, Padyukov L, Garred P, Frisch M, Karlson EW, Klareskog L, Alfredsson L, Ann Rheum Dis 2009 68 2 222 227 10.1136/ard.2007. 086314 18535114
6. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B, Ann Rheum Dis 2004 63 9 1090 1095 10.1136/ard.2003.014233 15308518 (Pubitemid 39120360)
7. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis-a randomized study. Hafstrom I, Rohani M, Deneberg S, Wornert M, Jogestrand T, Frostegard J, J Rheumatol 2007 34 9 1810 1816 17696277 (Pubitemid 350067638)
8. Treatment of early RA in clinical practice: a comparative study of two different DMARD/corticosteroid options. Svensson B, Ahlmen M, Forslind K, Clin Exp Rheumatol 2003 21 3 327 332 12846051 (Pubitemid 36747827)
9. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. Arthritis Rheum 1988 31 3 315 324 10.1002/art.1780310302 3358796 (Pubitemid 18091653)
10. Assessing disability in patients with rheumatoid arthritis. use of a Swedish version of the stanford health assessment questionnaire. Ekdahl C, Eberhardt K, Andersson SI, Svensson B, Scand J Rheumatol 1988 17 4 263 271 10.3109/03009748809098795 3187457
11. Measurement of patient outcome in arthritis. Fries JF, Spitz P, Kraines RG, Holman HR, Arthritis Rheum 1980 23 2 137 145 10.1002/art.1780230202 7362664 (Pubitemid 10164318)
12. Variations in population health status: results from a United Kingdom national questionnaire survey. Kind P, Dolan P, Gudex C, Williams A, BMJ 1998 316 7133 736 741 10.1136/bmj.316.7133.736 9529408 (Pubitemid 28121072)
13. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group, Health Policy 1990 16 3 199 208 10109801
14. EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise. Brooks RG, Jendteg S, Lindgren B, Persson U, Bjork S, Health Policy 1991 18 1 37 48 10.1016/0168-8510(91)90142-K 10112300
15. Validity of Euroqol-a generic health status instrument-in patients with rheumatoid arthritis. economic and health outcomes research group. Hurst NP, Jobanputra P, Hunter M, Lambert M, Lochhead A, Brown H, Br J Rheumatol 1994 33 7 655 662 10.1093/rheumatology/33.7.655 8019795 (Pubitemid 24222119)
16. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A, Br J Rheumatol 1997 36 5 551 559 10.1093/rheumatology/36.5.551 9189057
17. The alcohol use disorders identification test (AUDIT) in a college sample. Fleming MF, Barry KL, MacDonald R, Int J Addict 1991 26 11 1173 1185 1743817
18. Experience with the alcohol use disorders identification test (AUDIT) in Mexico. Medina-Mora E, Carreno S, De la Fuente JR, Recent Dev Alcohol 1998 14 383 396 10.1007/0-306-47148-5-19 9751955
19. Intoxication and hazardous use of alcohol: results from the 1992 finnish drinking habits study. Holmila M, Addiction 1995 90 6 785 792 10.1111/j.1360-0443.1995.tb02226.x 7633295
20. Is frequency of drinking an indicator of problem drinking? A psychometric analysis of a modified version of the alcohol use disorders identification test in Switzerland. Gmel G, Heeb JL, Rehm J, Drug Alcohol Depend 2001 64 2 151 163 10.1016/S0376-8716(01)00117-X 11543985 (Pubitemid 32816958)
21. Alcohol use disorder identification test (AUDIT): what does it screen? Performance of the AUDIT against four different criteria in a swedish population sample. Selin KH, Subst Use Misuse 2006 41 14 1881 1899 10.1080/ 10826080601025532 17162595 (Pubitemid 44949916)
22. Associations between AUDIT-C and mortality vary by age and sex. Harris AH, Bradley KA, Bowe T, Henderson P, Moos R, Popul Health Manag 2010 13 5 263 268 10.1089/pop.2009.0060 20879907
23. Estimating risk of alcohol dependence using alcohol screening scores. Rubinsky AD, Kivlahan DR, Volk RJ, Maynard C, Bradley KA, Drug Alcohol Depend 2010 108 1-2 29 36 20042299
24. Is the full version of the AUDIT really necessary? study of the validity and internal construct of its abbreviated versions. Meneses-Gaya C, Zuardi AW, Loureiro SR, Hallak JE, Trzesniak C, de Azevedo Marques JM, Machado-de-Sousa JP, Chagas MH, Souza RM, Crippa JA, Alcohol Clin Exp Res 2010 34 8 1417 1424 20491736
25. AUDIT-C, AUDIT-3 and AUDIT-QF in screening risky drinking among finnish occupational health-care patients. Kaarne T, Aalto M, Kuokkanen M, Seppa K, Drug Alcohol Rev 2010 29 5 563 567 10.1111/j.1465-3362.2010.00172.x 20887582
26. AUDIT and its abbreviated versions in detecting heavy and binge drinking in a general population survey. Aalto M, Alho H, Halme JT, Seppa K, Drug Alcohol Depend 2009 103 1-2 25 29 19395203
27. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). alcohol Use disorders identification test. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA, Arch Intern Med 1998 158 16 1789 1795 10.1001/archinte.158.16.1789 9738608 (Pubitemid 28421422)
28. Sex: a major predictor of remission in early rheumatoid arthritis? Forslind K, Hafstrom I, Ahlmen M, Svensson B, Ann Rheum Dis 2007 66 1 46 52 17158139 (Pubitemid 46044859)
29. Smoking at onset of rheumatoid arthritis (RA) and its effect on disease activity and functional status: experiences from BARFOT, a long-term observational study on early RA. Soderlin MK, Petersson IF, Bergman S, Svensson B, Scand J Rheumatol 2011 40 4 249 255 10.3109/03009742.2010.541495 21338325
30. Alcohol, host defence and society. Nelson S, Kolls JK, Nat Rev Immunol 2002 2 3 205 209 10.1038/nri744 11913071 (Pubitemid 37328767)
31. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI, Hepatology 1991 13 2 267 276 1995437
32. Regulation of human monocyte functions by acute ethanol treatment: decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production. Szabo G, Mandrekar P, Girouard L, Catalano D, Alcohol Clin Exp Res 1996 20 5 900 907 10.1111/j.1530-0277.1996.tb05269.x 8865966 (Pubitemid 26282325)
33. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the health, aging, and body composition study. Volpato S, Pahor M, Ferrucci L, Simonsick EM, Guralnik JM, Kritchevsky SB, Fellin R, Harris TB, Circulation 2004 109 5 607 612 10.1161/01.CIR.0000109503.13955.00 14769682 (Pubitemid 38202233)
34. Ethanol and pain sensitivity: effects in healthy subjects using an acute pain paradigm. Perrino AC Jr, Ralevski E, Acampora G, Edgecombe J, Limoncelli D, Petrakis IL, Alcohol Clin Exp Res 2008 32 6 952 958 10.1111/j.1530-0277.2008. 00653.x 18445106 (Pubitemid 351733076)
35. Absent window of opportunity in smokers with short disease duration. Data from BARFOT, a multicenter study of early rheumatoid arthritis. Soderlin MK, Bergman S, J Rheumatol 2011 38 10 2160 2168 10.3899/jrheum.100991 21807778
36. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug. Soderlin M, Petersson I, Geborek P, Scand J Rheumatol 2012 41 1 1 9 10.3109/03009742.2011.599073 22118371
37. Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the epidemiological investigation of rheumatoid arthritis and the Swedish rheumatology register cohorts. Saevarsdottir S, Wedren S, Seddighzadeh M, Bengtsson C, Wesley A, Lindblad S, Askling J, Alfredsson L, Klareskog L, Arthritis and rheumatism 2011 63 1 26 36 10.1002/art.27758 20862678
38. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Saevarsdottir S, Wallin H, Seddighzadeh M, Ernestam S, Geborek P, Petersson IF, Bratt J, van Vollenhoven RF, Ann Rheum Dis 2011 70 3 469 475 10.1136/ard.2010.139212 21149498
39. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Manfredsdottir VF, Vikingsdottir T, Jonsson T, Geirsson AJ, Kjartansson O, Heimisdottir M, Sigurdardottir SL, Valdimarsson H, Vikingsson A, Rheumatology (Oxford, England) 2006 45 6 734 740 10.1093/rheumatology/kei240 (Pubitemid 43985343)
40. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. Wolfe F, J Rheumatol 2000 27 3 630 637 10743800 (Pubitemid 30151338)
41. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Papadopoulos NG, Alamanos Y, Voulgari PV, Epagelis EK, Tsifetaki N, Drosos AA, Clin Exp Rheumatol 2005 23 6 861 866 16396705 (Pubitemid 43040515)
42. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British society for rheumatology biologics register. Hyrich KL, Watson KD, Silman AJ, Symmons DP, Rheumatology (Oxford, England) 2006 45 12 1558 1565 10.1093/rheumatology/kel149 (Pubitemid 44817065)
43. Anti-TNF-alpha agents are less effective for the treatment of rheumatoid arthritis in current smokers. Abhishek A, Butt S, Gadsby K, Zhang W, Deighton CM, J Clin Rheumatol 2010 16 1 15 18 10.1097/RHU.0b013e3181ca4a2a 20051749
44. Relationship between pack-year history of smoking and response to tumor necrosis factor antagonists in patients with rheumatoid arthritis. Mattey DL, Brownfield A, Dawes PT, J Rheumatol 2009 36 6 1180 1187 10.3899/jrheum.081096 19447930
45. Alcohol intake and markers of inflammation. Kesteloot H, Eur Heart J 2004 25 23 2075 2076 10.1016/j.ehj.2004.09.029 15571821 (Pubitemid 39572238)
46. Patient-reported 28 swollen and tender joint counts accurately represent RA disease activity and can be used to assess therapy responses at the group level. Riazzoli J, Nilsson JA, Teleman A, Petersson IF, Rantapaa-Dahlqvist S, Jacobsson LT, van Vollenhoven RF, Rheumatology (Oxford) 2010 49 11 2098 2103 10.1093/rheumatology/keq197
47. Patient-derived joint counts are a potential alternative for determining disease activity score. Kavanaugh A, Lee SJ, Weng HH, Chon Y, Huang XY, Lin SL, J Rheumatol 2010 37 5 1035 1041 10.3899/jrheum.090704 20156946
48. Differences in longitudinal disease and treatment characteristics of patients with rheumatoid arthritis replying and not replying to a postal questionnaire. Experience from a biologics register in southern Sweden. Soderlin MK, Jacobsson LT, Petersson IF, Englund M, Saxne T, Geborek P, J Rheumatol 2009 36 6 1166 1169 10.3899/jrheum.081027 19411397
49. Survey nonresponse is associated with increased mortality in patients with rheumatoid arthritis and in a community population. Kauppi M, Sokka T, Hannonen P, J Rheumatol 2005 32 5 807 810 15868613 (Pubitemid 40676487)
50. Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the health assessment questionnaire. Krishnan E, Murtagh K, Bruce B, Cline D, Singh G, Fries JF, J Rheumatol 2004 31 7 1320 1326 15229950 (Pubitemid 38879195)